|
|
|
|
  |
| NOTICES |
|
| Notice No. |
|
20170522-13 |
|
Notice Date |
|
22 May 2017 |
|
| Category |
|
Corporate Actions |
|
Segment |
|
Equity |
|
| Subject |
|
Amalgamation of Dishman Pharmaceuticals and Chemicals Ltd. |
|
|
|
|
|
| Content |
|
|
Trading members of the Exchange are hereby informed that, pursuant to the Scheme of Amalgamation as sanctioned by the Hon’ble High Court of Gujarat between Dishman Pharmaceuticals and Chemicals Ltd. with Dishman Carbogen Amcis Limited, Dishman Carbogen Amcis Limited has intimated the Record Date to determine the entitlement of shareholders of Dishman Pharmaceuticals and Chemicals Ltd. to equity shares of Dishman Carbogen Amcis Limited.
Trading Members are advised not to deal in the equity shares of Dishman Pharmaceuticals and Chemicals Ltd with effect from the under mentioned date:
|
COMPANY NAME
CODE
|
RECORD DATE
|
PURPOSE
|
NO DEALINGS FROM
|
|
Dishman Pharmaceuticals and Chemicals Ltd
(532526)
|
31/05/2017
|
The Scheme of Amalgamation: -
Upon the Scheme becoming effective and in consideration of the Amalgamation of Dishman Pharmaceuticals and Chemicals Ltd. into Dishman Carbogen Amcis Limited, Dishman Carbogen Amcis Limited shall issue and allot Equity Shares to the shareholders of Dishman Pharmaceuticals and Chemicals Ltd. in the following share exchange ratio:
“01 equity share of Dishman Carbogen Amcis Limited for every 01 equity Share held in Dishman Pharmaceuticals and Chemicals Ltd”.
|
30/05/2017
DR-041/2017-2018
|
Trading Members of the Exchange are requested to take note of the above.
Mangesh Tayde
Senior Manager –Listing Operations (CRD)
Contact No. 2272 8846
May 22, 2017
|
|